Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Sarepta partners with UK's Summit on Duchenne drugs
Wednesday, October 05, 2016Sarepta Therapeutics Inc said it secured the European rights to Summit Therapeutics Plcs experimental Duchenne muscular dystrophy DMD drug as it looks to build on its lead in treating the fatal musclewasting disease Summits shares doubled to pence...
Roche gets boost from FDA in bid to expand uses for Actemra
Wednesday, October 05, 2016The US Food and Drug Administration has granted breakthrough status to Roches rheumatoid arthritis medication Actemra for giant cell arteritis the Swiss drugmaker said a step which could help it broaden applications for the medicine Giant cell arter...
Aralez to Acquire U.S. Rights From AstraZeneca to Beta Blocker Toprol-XL®
Wednesday, October 05, 2016Aralez Pharmaceuticals Inc a global specialty pharmaceutical company today announced it will acquire the US rights to ToprolXL metoprolol succinate and its Authorized Generic AG pursuant to an agreement entered into between AstraZeneca and Aralez Pha...
Vivus and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra
Tuesday, October 04, 2016VIVUS Inc says additionally Metuchen will be responsible for royalties due to Mitsubishi Tanabe Pharma corporation based on net sales VIVUS and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra VIVUSSigned commerc...
AstraZeneca licenses inflammatory disease candidate to Allergan
Tuesday, October 04, 2016Britains AstraZeneca said it had licensed a potential medicine for inflammatory diseases to Allergan for an upfront payment of million and potential additional payments of up to billion AstraZeneca said the drug developed by its global biologics r...
House Committee Taps Mylan for More Information on EpiPen Price Figures
Tuesday, October 04, 2016A US House committee sent a letter to Mylan NV demanding a fuller explanation of why the company omitted key information that it used to calculate the profit figure for the lifesaving EpiPen drug that its chief executive provided during a congression...
Samsung Bioepis seeks Europe approval for copy of Herceptin breast cancer drug
Tuesday, October 04, 2016South Koreas Samsung Bioepis a maker of cheaper copies of complex biotech drugs known as biosimilars is seeking regulatory approval in Europe to sell its copy of Swiss giant Roches blockbuster breast cancer drug Herceptin Samsung Bioepis part of Sou...
J&J psoriasis drug tops placebo, Humira in late stage study
Monday, October 03, 2016An experimental biotech drug developed by Johnson Johnson proved more effective at clearing moderate to severe cases of the skin condition plaque psoriasis than a placebo or Abbvie Incs bigselling Humira according to data from a late stage study pre...
Morphosys moves closer to getting first antibody drug on market
Monday, October 03, 2016German biotech Morphosys moved a step closer to getting its first antibody drug onto the market as its licensee Johnson Johnson unit Jenssen reported positive results from a phase study of psoriasis drug guselkumab Johnson Johnson said earlier th...
Novo Nordisk Bets on Riskier Insulin Research
Monday, October 03, 2016Nearly years ago executives at Novo Nordisk AS wondered whether the companys decadeslong quest to make everbetter insulin had finally come to an end The trigger was an impressive set of results for the companys newest insulin that suggested the pro...
